• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[湖南省人群甲型H1N1流感大流行病毒感染的血清学调查]

[Serological survey of pandemic influenza A (H1N1) virus infection among population in Hunan Province].

作者信息

Liu Yun-zhi, Wang Wu-hong, Li Fang-cai, Yang Hao, Zhang Hong, Deng Zhi-hong, Wang Yuan, Chen Chang, Li Wen-chao, Zhang Heng-jiao, Liu Fu-qiang, Zhang Si-yu, Hu Shi-xiong

机构信息

Hunan Provincial Center for Disease Control and Prevention, Changsha 410005, China.

出版信息

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Feb;25(1):17-9.

PMID:21789845
Abstract

OBJECTIVE

To understand the infection condition and analytical methods of Influenza A (H1N1) virus in the population of Hunan Province during different periods.

METHODS

Quick surveys on the positive rate of Influenza A (H1N1) virus hemagglutination inhibition (HI) test have been conducted for 5 times successively from November 2009 to March 2010 in 14 medical and health institutions of Changsha city, whose results were then compared with those from the sampling surveys of whole Hunan province.

RESULTS

2131 subjects were involved in this study; the total population standardized rates of antibody positive investigated for 5 times were 9.32% , 14.62%, 31.08%, 28.43% and 22.80% respectively; the population of 6-17-years-old has the highest rate of antibody positive; only 9.84% of the antibody positive subjects attributed to vaccine inoculation; there was no significant difference in the standardized positive rates between the quick serological surveys and the corresponding sampling survey of Hunan province (P > 0.05).

CONCLUSION

The positive rate of A (H1N1) virus antibody reached the peak in late January 2010; quick investigations in small region could be used to evaluate the infection prevalence during pandemic of infectious diseases.

摘要

目的

了解湖南省不同时期人群甲型H1N1流感病毒的感染状况及分析方法。

方法

2009年11月至2010年3月,在长沙市14家医疗卫生机构连续5次对甲型H1N1流感病毒血凝抑制(HI)试验阳性率进行快速调查,并与湖南省抽样调查结果进行比较。

结果

本研究共纳入2131名受试者;5次调查的抗体阳性人群标准化总率分别为9.32%、14.62%、31.08%、28.43%和22.80%;6-17岁人群抗体阳性率最高;抗体阳性者中仅9.84%归因于疫苗接种;快速血清学调查与湖南省相应抽样调查的标准化阳性率无显著差异(P>0.05)。

结论

甲型H1N1流感病毒抗体阳性率于2010年1月下旬达到高峰;小区域快速调查可用于评估传染病大流行期间的感染流行情况。

相似文献

1
[Serological survey of pandemic influenza A (H1N1) virus infection among population in Hunan Province].[湖南省人群甲型H1N1流感大流行病毒感染的血清学调查]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Feb;25(1):17-9.
2
[A survey of levels of antibodies against influenza viruses in the population of Wuxi City].[无锡市人群流感病毒抗体水平调查]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Oct;25(5):351-4.
3
AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.AS03(A)- 佐剂季节性流感 A(H1N1)2009 疫苗,适用于 85 岁以下成年人。
Clin Infect Dis. 2010 Sep 15;51(6):668-77. doi: 10.1086/655830.
4
Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.对2009年甲型H1N1流感大流行病毒的交叉反应性抗体应答。
N Engl J Med. 2009 Nov 12;361(20):1945-52. doi: 10.1056/NEJMoa0906453. Epub 2009 Sep 10.
5
Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents.2009 年甲型 H1N1 流感病毒单价疫苗在儿童和青少年中的免疫原性和安全性。
Vaccine. 2010 Aug 16;28(36):5864-70. doi: 10.1016/j.vaccine.2010.06.059. Epub 2010 Jul 13.
6
Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: a phase III open-label single-arm study.在年轻和老年受试者中含大流行 A(H1N1) 抗原的三价单价季节性流感疫苗的安全性和免疫原性:一项 III 期开放性单臂研究。
Vaccine. 2011 Feb 1;29(6):1228-34. doi: 10.1016/j.vaccine.2010.11.092. Epub 2010 Dec 15.
7
Serological survey of 2009 H1N1 influenza in residents of Beijing, China.中国北京居民中 2009 年 H1N1 流感的血清学调查。
Epidemiol Infect. 2011 Jan;139(1):52-8. doi: 10.1017/S0950268810002189. Epub 2010 Sep 21.
8
A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity.系统性红斑狼疮患者接种 A/H1N1 流感疫苗:安全性和免疫原性。
Vaccine. 2011 Jan 10;29(3):444-50. doi: 10.1016/j.vaccine.2010.10.081. Epub 2010 Nov 13.
9
Evaluation of adjuvanted pandemic H1N1(2009) influenza vaccine after one and two doses in young children.评价佐剂季节性 H1N1(2009)流感疫苗在幼儿中接种一剂和两剂后的效果。
Pediatr Infect Dis J. 2011 May;30(5):402-7. doi: 10.1097/INF.0b013e3182068f33.
10
Factors associated with infection by 2009 pandemic H1N1 influenza virus during different phases of the epidemic.与 2009 年大流行 H1N1 流感病毒在流行不同阶段感染相关的因素。
Int J Infect Dis. 2011 Oct;15(10):e695-701. doi: 10.1016/j.ijid.2011.05.012. Epub 2011 Jul 20.